據報摩通(JPM.US)增設團隊專注公開和私人市場定製化融資
《彭博》報道,摩根大通(JPM.US)在其商業和投行業務增設「策略性融資方案」團隊,專注公開和私人市場的定製化融資結構。
團隊將由一般產業槓桿融資主管Warfield Price及公司結構全球主管Masi Yamada共同領導,並將向全球資本市場主管Kevin Foley及私募銷售與公司衍生性商品全球主管Brad Tully彙報。報道引述公司內部備忘指,該業務將為銀行、市場及銷售部門之間的合作,最初將專注於結構化私人解決方案、基建融資、策略性資產支援證券融資和直接貸款。
報道指,有關安排旨在捕捉公開市場和私人市場的整合機會,越來越多美國公司選擇更長期保持私有化,客戶需求也日益複雜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.